Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Study reveals 'superhero DNA'
DNA
The findings could be a starting point from which to investigate other changes or anomalies in developing therapies.
Research reveals genetic disease resilience
 
An international team of researchers have studied a database of nearly 600,000 people revealing that 13 were born with ‘superhero DNA’.  

Published in Nature Biotechnology, the approach reveals that 13 healthy people should have developed one of eight severe genetic diseases. The next step is to unravel why.

In a pioneering approach to genetic studies, the focus was directed at the DNA of those who remain healthy, rather than those who became ill. The findings could be a starting point from which to investigate other changes or anomalies in developing therapies.

In an interview with the BBC, Dr Eric Schadt from the Icahn School of Medicine at Mount Sinai Hospital in New York, said: “Most genomic studies focus on finding the cause of a disease, but we see tremendous opportunity in figuring out what keeps people healthy.”

However, progress with the findings has been limited by consent rules signed by the database of DNA sample providers. Despite discovering 13 ‘genetic superheroes’, the scientists are unable to trace them. Pulling into question the ethics behind genetic data sharing, the study is an example of what can be achieved through anonymous genetic and clinical data.

Talking to the BBC, Dr Matthew Hurles, from the Wellcome Trust Sanger Institute, said: “The full benefits of such altruistic data sharing is only fully realised when it becomes possible to go back to the resilient individual to try and understand how their resilience is achieved.”

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.